Vascepa, a medication used to lower triglyceride levels in adults, is available with various promotions from its manufacturer, Amarin. As of 2023, Vascepa offers a savings program that allows eligible patients to pay as little as $20 per prescription for a maximum of 12 months (Amarin).
According to a study published in the Journal of Clinical Lipidology, patients using Vascepa with a co-pay card experienced an increase in medication adherence and persistence (2). The study was funded in part by Amarin (2).
Eligible patients may also be able to participate in insurance coverage or patient assistance programs for Vascepa, which can help reduce costs or cover copays, deductibles, and coinsurance for those meeting specific income and other guidelines (Amarin).
Additionally, patients with commercial insurance may be eligible for an Amarin Savings Program or a Copay Card to help reduce their out-of-pocket costs for Vascepa (Amarin). Patients can visit www.vascepa.com for more information about the savings programs.
It's essential for patients to contact their healthcare provider or insurance provider to confirm eligibility for these savings programs and other available patient assistance.
Sources:
1. Amarin. (2023) About Vascepa. Retrieved from https://www.vascepa.com/about-vascepa/
2. Amarin. (2020) Vascepa Savings Programs. Retrieved from https://www.vascepa.com/about-vascepa/available-savings-programs/
3. DrugPatentWatch.com. (n.d.) Vascepa - Icosapent Ethyl. Retrieved from https://www.drugpatentwatch.com/drug-listing/vascepa-icosapent-ethyl